As a start-up developing child-protection software for smartphones, we have always been a more natural fit for conscientious investment rather than pure capitalists. Plus, with a lead-time to market longer than your average enterprise SaaS product (which typically can get an minimum viable product out withinsix6 months), we have also been more suitable for patient capital – where there is no immediate race to 10X returns and a quick exit, but rather an eagerness to hold horses for the bigger pay-out, albeit further down the track. However, when you are raising a seed round there is invariably an element of…

Want to continue reading?

Introductory offer: Sign up today and pay €200 for an annual membership, a saving of €100.

Subscribe

Cancel anytime.

Are you already a member? .